Evidence map›Paper›PMID 31255466›Full record

ArticleMolecular cell2019

EXD2 Protects Stressed Replication Forks and Is Required for Cell Viability in the Absence of BRCA1/2.

Jadwiga Nieminuszczy, Ronan Broderick, Marina A Bellani, Elizabeth Smethurst, Rebekka A Schwab, Veronica Cherdyntseva, Theodora Evmorfopoulou, Yea-Lih Lin, Michal Minczuk, Philippe Pasero and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular cell, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 4 countries.

Jadwiga NieminuszczyThe Institute of Cancer Research, London, UK.
Ronan BroderickThe Institute of Cancer Research, London, UK.
Marina A BellaniLaboratory of Molecular Gerontology, National Institute on Aging, Baltimore, MD, USA.
Elizabeth SmethurstInstitute of Molecular Medicine, Oxford, UK.
Rebekka A SchwabInstitute of Molecular Medicine, Oxford, UK.
Veronica CherdyntsevaLaboratory of Genetics, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
Theodora EvmorfopoulouLaboratory of Genetics, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
Yea-Lih LinInstitut de Génétique Humaine, CNRS, Université de Montpellier, Montpellier, France.
Michal MinczukMRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK.
Philippe PaseroInstitut de Génétique Humaine, CNRS, Université de Montpellier, Montpellier, France.
Sarantis GagosLaboratory of Genetics, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
Michael M SeidmanLaboratory of Molecular Gerontology, National Institute on Aging, Baltimore, MD, USA.
Wojciech NiedzwiedzThe Institute of Cancer Research, London, UK. Electronic address: wojciech.niedzwiedz@icr.ac.uk.
Biomedical Research Foundation of the Academy of Athens · GRInstitute of Cancer Research · GBNational Institute on Aging · USInstitut de Génétique Humaine · FRMRC Mitochondrial Biology Unit · GBUniversité de Montpellier · FR

Funding

Repair of localized DNA damageZIAAG000746 · NIA · NATIONAL INSTITUTE ON AGING · PI SEIDMAN, MICHAEL · 2009 to 2025
$30.0M
Repair of localized DNA damageZ01AG000746 · NIA · NATIONAL INSTITUTE ON AGING · PI SEIDMAN, MICHAEL · 2007 to 2008
$607k
Cancer Research UK 24881Intramural NIH HHS Z01 AG000746Medical Research Council MC_UU_00015/4Medical Research Council MC_UU_00015/7
6 · The paper itself

Abstract

Accurate DNA replication is essential to preserve genomic integrity and prevent chromosomal instability-associated diseases including cancer. Key to this process is the cells' ability to stabilize and restart stalled replication forks. Here, we show that the EXD2 nuclease is essential to this process. EXD2 recruitment to stressed forks suppresses their degradation by restraining excessive fork regression. Accordingly, EXD2 deficiency leads to fork collapse, hypersensitivity to replication inhibitors, and genomic instability. Impeding fork regression by inactivation of SMARCAL1 or removal of RECQ1's inhibition in EXD2

Indexed as

BRCA1 ProteinBRCA2 ProteinDNA HelicasesDNA ReplicationExodeoxyribonucleasesGenomic InstabilityHeLa CellsHumansNeoplasmsRecQ HelicasesSynthetic Lethal MutationsBRCA1 ProteinBRCA1 protein, humanBRCA2 ProteinDNA HelicasesEXD2 protein, humanExodeoxyribonucleasesRecQ HelicasesRECQL protein, humanSMARCAL1 protein, humanBRCA1BRCA2DNA replicationEXD2EXDL2fork regression

Identifiers

PMID31255466
PMCPMC6695479
OpenAlexW2955245459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.